| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.15B | 2.01B | 1.81B | 1.51B | 1.23B |
| Gross Profit | 1.32B | 1.24B | 1.10B | 933.60M | 782.00M |
| EBITDA | 344.30M | 357.50M | 323.60M | 271.30M | 260.40M |
| Net Income | 122.20M | 153.40M | 142.50M | 120.30M | 117.50M |
Balance Sheet | |||||
| Total Assets | 1.48B | 1.32B | 1.13B | 974.40M | 888.40M |
| Cash, Cash Equivalents and Short-Term Investments | 70.80M | 125.30M | 195.30M | 191.60M | 198.60M |
| Total Debt | 474.80M | 415.10M | 319.60M | 301.30M | 283.20M |
| Total Liabilities | 858.80M | 749.20M | 598.80M | 525.60M | 456.00M |
| Stockholders Equity | 625.20M | 570.50M | 530.90M | 446.00M | 429.20M |
Cash Flow | |||||
| Free Cash Flow | 73.70M | 70.00M | 112.70M | 149.60M | 231.20M |
| Operating Cash Flow | 337.00M | 310.90M | 310.80M | 252.90M | 285.50M |
| Investing Cash Flow | -284.50M | -217.10M | -191.20M | -100.80M | -54.00M |
| Financing Cash Flow | -107.00M | -163.80M | -115.90M | -159.10M | -69.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | £29.21B | 7.58 | 13.57% | 3.25% | 1.05% | -20.25% | |
70 Outperform | £7.38B | 11.60 | 5.08% | 4.02% | 0.82% | 160.81% | |
68 Neutral | £1.51B | 14.01 | 20.47% | 3.34% | 8.06% | 5.15% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | £6.60B | 298.74 | 0.69% | 1.18% | 14.13% | -96.12% | |
60 Neutral | £651.79M | 11.48 | -68.82% | 6.46% | -0.67% | 2.43% | |
48 Neutral | £1.35B | -26.58 | -59.21% | 2.50% | 5.98% | -371.14% |